Table 2: Attributable burden on HRQoL in patients with onco-hematological disease: comparison with chronic tumors or diseases.

Disease SF-12 score
Average±sd
Attributable Burden on HRQoL Comparison with Onco-hematologic Disease
ANOVA 1 way
p
Major Depression
(N=37)
33.8±9.2 5.6±3.6 df 1,95,96
F=0.255
0.615
Multiple Sclerosis
(N=201)
29.5± 7.3 7.0±3.5 df 1,261,9262
F=4.673
0.032
Wilson Disease
(N=23)
33.8±9.0 4.4±1.7 df 1,83,84
F=5.623
0.020
Carotidal atherosclerosis
(N=46)
30.6±8.1 6.2±5.0 df 1,106,107
F=0.115
0.735
Celiac disease
(N=60)
35.83±5.72 2.4±1.0 df 1,120,121
F= 67.959
<0.00001
Solid tumors
(N=151)
32.34±6.764 4.67±6.64 df 1,211,212
F= 0.770
0.381
Onco-hematological tumors
(N=62)
32.60±5.43 5.44±2.93